Follow
Carolina Venda Nova
Carolina Venda Nova
PhD Student, UCL
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Treatment outcomes in trigeminal neuralgia–a systematic review of domains, dimensions and measures
CV Nova, JM Zakrzewska, SR Baker, RN Riordain
World neurosurgery: X 6, 100070, 2020
462020
Patient reported outcome measures in trigeminal neuralgia–a systematic review of psychometric performance
C Venda Nova, JM Zakrzewska, S R. Baker, R Ni Riordain
European Journal of Pain 25 (7), 1449-1461, 2021
112021
Accuracy of the painDETECT screening questionnaire for detection of neuropathic components in hospital-based patients with orofacial pain: a prospective cohort study
DJ Jafree, JM Zakrzewska, S Bhatia, C Venda Nova
The journal of headache and pain 19, 1-9, 2018
112018
Eosinophilia associated with disease exacerbations in a patient with pyostomatitis vegetans
M Shephard, C Venda Nova, TA Hodgson
British Journal of Dermatology 173 (6), 1556-1557, 2015
62015
An international Delphi survey and consensus meeting to define the core outcome set for trigeminal neuralgia clinical trials
C Venda Nova, R Ni Riordain, SR Baker, JM Zakrzewska
European Journal of Pain 27 (1), 86-98, 2023
52023
They could have cut my head off and I wouldn’t have cared
C Venda Nova, JM Zakrzewska, BSR Ni Riordain, SR Baker
A qualitative study of patients’ experiences and the impact of trigeminal …, 2022
2*2022
Looking beyond the obvious: the importance of outcomes and outcomes measures in trigeminal neuralgia
CV Nova, RN Riordain, SR Baker, JM Zakrzewska
Pain 162 (9), 2456, 2021
22021
The specialist management of non-temporomandibular orofacial pain: maxillofacial surgery’s known unknown?
DH Awal, K Amin, C Venda-Nova, A Naqvi, J Zakrzewska
British Journal of Oral and Maxillofacial Surgery 57 (8), 749-754, 2019
22019
Development of a Core Outcome Set for Trigeminal Neuralgia for use in clinical trials
CV Nova, S Baker, R Riordain, J Zakrzewska
CEPHALALGIA 43 (1 supp), 316-317, 2023
2023
Outcomes of treatment and psychometric performance of patient reported outcomes in Trigeminal Neuralgia-Two Systematic Reviews
C Venda Nova, JM Zakrzewska, SR Baker, R Ni Riordain
JOURNAL OF HEADACHE AND PAIN 22 (SUPPL 2), 2021
2021
Thalidomide therapy for refractory mucosal disease: benefit and risks over 10 years
T Saunsbury, M Harte, C Venda-Nova, K Patel, T Hodgson
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 131 (4), e115 …, 2021
2021
Checklists for safe prescribing in oral medicine clinics
MK Shephard, CV Nova, P Thakrar, T Hodgson
British Dental Journal 223 (9), 693-698, 2017
2017
EP2098. Patient-completed screening tools have poor diagnostic accuracy for neuropathic orofacial pain in a hospital-based cohort
D Jafree, J Zakrzewska, C Venda-Nova
EUROPEAN JOURNAL OF NEUROLOGY 24, 284-284, 2017
2017
Clinical decision making in suspected oral squamous cell carcinoma
M Shephard, CV Nova, P Thakar, T Hodgson
ORAL DISEASES 20, 17-17, 2014
2014
OI0264 Compliance with work-up and monitoring for azathioprine and mycophenolate mofetil
MK Shephard, CV Nova, TA Hodgson
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117 (5), e384, 2014
2014
OI0265 Demographic changes in oral squamous cell carcinoma diagnoses over a 9-year period
M Shephard, P Thakrar, CV Nova, D Pinder, C Wilson, TA Hodgson
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117 (5), e342, 2014
2014
Pain Catastrophizing Scale as predictor for a multidisciplinary care pathway in facial pain patients
CV Nova, J Zakrzewska, R McMillan
The system can't perform the operation now. Try again later.
Articles 1–17